In this episode of #AskDrDurie, Dr. Brian Durie explores options for myeloma treatment if a patient isn’t receiving a full response from Pomalyst.

Dr. Brian G.M. Durie is the Chairman of the Board of Directors of the International Myeloma Foundation. He began studying multiple myeloma over 30 years ago, and is recognized around the world as one of the top myeloma doctors.

Previous Post
#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?
Next Post
#AskDrDurie: Is there a test available for measuring Minimal Residual Disease (MRD)?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.